Completed Biomedical ML Research · Pejaver Lab
Rare Disease Prediction From Clinical Notes
A Mount Sinai research project using clinical notes, rare-disease ontology mappings, and BERT-based models to identify patients with rare diseases from MIMIC-IV.
Data
1M+ clinical notes
Model
ClinicalBERT pipeline
Result
about 85% AUC
Lab
Pejaver Lab, Icahn School of Medicine at Mount Sinai
PI
Professor Vikas Pejaver
Mentor
Mohammed Ghouse Syed
Dates
May 2025 - Aug 2025
Pipeline
Project Summary
Rare diseases are difficult to detect early because useful evidence is often scattered through long, messy clinical notes. The project turned unstructured MIMIC-IV notes into a structured patient-level dataset by using Orphanet disease information, ICD mappings, diagnosis timing, and matched controls.
I filtered notes to include only text written before the rare disease diagnosis, then fine-tuned ClinicalBERT-style models using overlapping token windows to handle long notes. The final BERT-based pipeline delivered roughly 85% AUC in identifying rare-disease patients from MIMIC-derived experiments.
Beyond prediction, the project explored interpretability: extracting high-attention tokens, mapping them back to words in notes, and producing highlighted evidence lists that a clinical collaborator could inspect.
Core Components
Clinical-note dataset
Processed 1M+ notes from MIMIC-IV and grouped pre-diagnosis notes into patient-level text blocks for modeling.
Rare-disease mapping
Used Orphanet rare-disease metadata and exact ICD-10 to ICD-9 mappings to construct a structured disease cohort.
BERT pipeline
Fine-tuned ClinicalBERT with sliding 512-token windows, focal loss, and consistent train/validation/test splits.
Interpretability
Built attention-based note highlighting to surface the words and phrases influencing rare-disease predictions.
Clinical NLP
The hard part was making noisy notes usable without leaking the diagnosis.
The project was not just a model fine-tuning exercise. A large part of the work was cohort definition: mapping rare diseases, choosing exact ICD matches, identifying the first diagnosis date, and ensuring the model only saw notes from before that point.
- Data source
- MIMIC-IV clinical notes and diagnosis records, with patient-level aggregation before first diagnosis.
- Disease mapping
- Orphanet rare-disease metadata, exact ICD-10 mappings, and exact ICD-10 to ICD-9 General Equivalence Mappings.
- Modeling
- ClinicalBERT fine-tuning with 512-token sliding windows, 256-token stride, focal loss, and early stopping.
- Evaluation
- Consistent splits and cross-validation experiments, with AUC used as the main discrimination metric.
Presentation
The project presentation is embedded below and available as a direct PDF.